Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$12.44 - $19.45 $631,155 - $986,815
-50,736 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$16.24 - $29.83 $76,133 - $139,843
-4,688 Reduced 8.46%
50,736 $887,000
Q4 2020

Feb 02, 2021

BUY
$14.28 - $29.73 $387,330 - $806,396
27,124 Added 95.84%
55,424 $1.42 Million
Q3 2020

Nov 05, 2020

SELL
$12.39 - $26.15 $21,496 - $45,370
-1,735 Reduced 5.78%
28,300 $371,000
Q2 2020

Aug 12, 2020

BUY
$14.59 - $36.07 $438,210 - $1.08 Million
30,035 New
30,035 $821,000

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $25.6M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.